Bet v 1 from Birch Pollen Is a Lipocalin-like Protein Acting as Allergen Only When Devoid of Iron by Promoting Th2 Lymphocytes
Open Access
- 1 June 2014
- journal article
- clinical trial
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (25) , 17416-17421
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodiesJournal of Allergy and Clinical Immunology, 2012
- Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylasesJournal of Cellular Biochemistry, 2012
- Crystallographically Mapped Ligand Binding Differs in High and Low IgE Binding Isoforms of Birch Pollen Allergen Bet v 1Journal of Molecular Biology, 2012
- Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001Immunobiology, 2010
- Detection of Bet v1, Bet v2 and Bet v4 Specific IgE Antibodies in the Sera of Children and Adult Patients Allergic to Birch Pollen: Evaluation of Different IgE Reactivity Profiles Depending on Age and Local SensitizationInternational Archives of Allergy and Immunology, 2010
- Pre-calculated protein structure alignments at the RCSB PDB websiteBioinformatics, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The Bet v 1 fold: an ancient, versatile scaffold for binding of large, hydrophobic ligandsBMC Ecology and Evolution, 2008
- X-ray and NMR structure of Bet v 1, the origin of birch pollen allergyNature Structural & Molecular Biology, 1996